• Microcytic: MCV < 80 fL → TICS: Thalassaemia, Iron deficiency, Chronic disease (rare), Sideroblastic
• Normocytic: MCV 80–100 fL → ABCD: Acute blood loss, Bone marrow failure, Chronic disease,
Destruction (haemolysis)
• Macrocytic: MCV > 100 fL → B12/folate deficiency, liver disease, alcohol, reticulocytosis, hypothyroidism,
drugs (hydroxyurea, AZT)
• MCV: Mean corpuscular volume → classifies anaemia
• MCH: Mean corpuscular Hb → low in iron deficiency
• RDW: ↑ in iron deficiency, variable cell size
• Morphology clues:
o Target cells → liver disease, thalassaemia
o Teardrop cells → myelofibrosis
o Schistocytes → MAHA
o Spherocytes → AIHA or hereditary spherocytosis
• Iron deficiency – most common worldwide
• Thalassaemia – microcytic, hypochromic, normal iron
• Sideroblastic anaemia – ring sideroblasts in marrow
• Chronic disease – occasionally microcytic
• Megaloblastic: B12 or folate deficiency
• Non-megaloblastic: Alcohol, liver disease, hypothyroidism
• Drugs: Methotrexate, hydroxyurea, phenytoin, zidovudine
• Reticulocytosis: falsely raises MCV due to large retics
• Acute blood loss
• Anaemia of chronic disease
• Renal disease – ↓ erythropoietin
• Haemolysis – may be normocytic
• Bone marrow failure – aplastic anaemia, myelodysplasia
• Low ferritin, high TIBC, low serum iron
• Causes: blood loss (e.g. GI, menstruation), poor intake, malabsorption (e.g. coeliac)
• Features: koilonychia, angular stomatitis, pica
• Rx: oral iron (ferrous sulfate), IV iron if intolerant/malabsorption
• α-thalassaemia: gene deletion, SE Asia; HbH, hydrops fetalis
• β-thalassaemia: point mutation, Mediterranean; target cells
• Trait vs major: major needs transfusion + chelation
• Normal iron studies, unlike iron deficiency
• Defective haem synthesis → ring sideroblasts (Prussian blue)
• Causes: congenital, alcohol, lead, isoniazid, myelodysplasia
• Iron overload with microcytic anaemia
• High ferritin, ↑ transferrin saturation
• ↓ serum iron, ↓ TIBC, normal/high ferritin
• Due to inflammatory cytokines → hepcidin inhibits iron release
• Associated with RA, CKD, infections, malignancy
• Treat underlying cause; consider EPO in CKD
• B12 deficiency: vegan diet, pernicious anaemia, ileal disease
• Folate deficiency: alcoholism, poor diet, pregnancy, drugs (MTX)
• Features: glossitis, neuro signs (B12 only), pancytopenia
• Rx: IM B12; never give folate before B12!
• Pancytopenia with hypocellular marrow
• Causes: idiopathic, drugs (chloramphenicol, chemo), radiation, viruses (EBV, parvovirus B19)
• Rx: supportive care, bone marrow transplant, immunosuppression
• Normocytic anaemia due to ↓ erythropoietin
• May be exacerbated by chronic inflammation, reduced RBC survival
• Rx: EPO-stimulating agents + iron supplementation
• Step 1: Confirm anaemia (Hb low for age/sex)
• Step 2: Check MCV → classify as micro/normo/macrocytic
• Step 3: Look at reticulocyte count – low in marrow failure, high in haemolysis/bleeding
• Step 4: Assess iron status, B12/folate, renal function, CRP
• Step 5: Blood film and further tests guided by initial findings
————————————————————————————————————————————————————————————————————————————————————————————————————————-
Author & Educational Disclaimer
Author:
Dr Phillip Cockrell BM FRCP DipClinEd
Dr Phillip Cockrell is a UK Consultant Physician in Internal Medicine, currently working at Queen Alexandra Hospital, Portsmouth University Hospitals NHS Trust. He has previously worked as a registrar across Intensive Care Medicine, Gastroenterology, Cardiology, Stroke Medicine, Acute Medicine, and Respiratory Medicine.
He has held senior leadership roles including Associate Clinical Director of the Acute Medical Unit, Clinical Director of Internal Medicine, and Chief of Medicine. Dr Cockrell has over 15 years’ experience in postgraduate medical education, having lectured extensively across the MRCP syllabus and contributed to MRCP revision teaching and course development.
Dr Cockrell holds a Bachelor of Medicine (BM), Fellowship of the Royal College of Physicians (FRCP), and a Diploma in Clinical Education (DipClinEd). His teaching approach is based on structured consolidation of complex medical topics to support efficient and effective revision for postgraduate examinations.
Purpose of this content:
The material on this page is intended solely for educational purposes to support revision for the MRCP (UK) Part 1 examination. It reflects examination-relevant principles of internal medicine and is designed to aid learning and pattern recognition.
Medical disclaimer:
This content is designed for postgraduate medical examination revision and does not constitute medical advice, diagnosis, or treatment guidance and must not be used as a substitute for professional clinical judgement, local guidelines, or specialist consultation. Clinical decisions should always be made in the context of individual patient circumstances and current national guidance.